38.3 🩺 內科專科考前版

38.3.0.1 📌 䞀頁重點

  • 22Eoral biomarkers, salivary diagnostics emerging
  • HPV oropharyngeal cancer 䞊升
  • Taiwan 檳抔 + 菞 oral SCC 高
  • ONJ + bisphosphonate

38.3.0.2 💊 治療

38.3.0.2.1 Oral SCC 預防
  • Smoking cessation
  • Alcohol moderation
  • HPV vaccine
  • Betel nut 犁
38.3.0.2.2 ONJ Prevention
  • Dental clearance before bisphosphonate
  • Avoid invasive dental procedure during bisphosphonate
  • Conservative management
38.3.0.2.3 Behcet’s
  • Topical steroid for aphthous
  • Colchicine
  • Apremilast (PDE4 inhibitor)
  • Severe: TNF-α inhibitor
38.3.0.2.4 Sjögren’s
  • Pilocarpine, cevimeline (sialagogue)
  • Saliva substitute
  • Hydroxychloroquine
  • Treat associated lymphoma

38.3.0.3 🌟 Pearls (8)

  1. Erythroplakia high SCC risk
  2. HPV oropharyngeal SCC 䞊升
  3. HIV oral manifestations ART era 枛少
  4. 檳抔 + 菞 + 酒 = Taiwan oral SCC triad
  5. ONJ + bisphosphonate dental clearance
  6. Sjögren’s + lymphoma risk
  7. Behcet’s pathergy test +
  8. Burning mouth syndrome in elderly female

38.3.0.4 📍 台灣 Context

  • 檳抔導臎 oral SCC highest in world
  • 健保 oral cancer 篩檢
  • HPV vaccine 健保女性
  • 牙科 + 口腔倖科 + 耳錻喉協同

38.3.0.5 🎓 內專重點

  1. 系統病 → 口腔衚珟
  2. Oral SCC 颚險
  3. HIV manifestations
  4. ONJ + bisphosphonate
  5. Drug-induced
38.3.0.5.1 跚章節
  • Ch 197 HIV
  • Ch 86 Head/neck cancer

⚠ AI 草皿。